Principal Financial Group
ALT icon

Principal Financial Group’s Altimmune ALT Stock Holding History

Principal Financial Group’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10,590
Closed -$70.4K – 2231
2024
Q2 		$70.4K Buy
+10,590
New +$78.1K ﹤0.01% 2250
2021
Q4 		– Sell
-113,509
Closed -$1.28M – 2530
2021
Q3 		$1.28M Sell
113,509
-1,982
-2% -$24.1K ﹤0.01% 1952
2021
Q2 		$1.14M Sell
115,491
-59,467
-34% -$813K ﹤0.01% 2011
2021
Q1 		$2.47M Buy
174,958
+13,326
+8% +$215K ﹤0.01% 1821
2020
Q4 		$1.82M Buy
+161,632
New +$1.9M ﹤0.01% 1812
2017
Q2 		– Sell
-37
Closed -$9K – 2258
2017
Q1 		$9K Buy
37
+3
+9% +$1.6K ﹤0.01% 2206
2016
Q4 		$34K Hold
34
– – ﹤0.01% 2215
2016
Q3 		$30K Hold
34
– – ﹤0.01% 2155
2016
Q2 		$25K Buy
+34
New +$23.3K ﹤0.01% 2155

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Principal Financial Group's ALT Position: Q3 2024 in Review

Principal Financial Group sold out of Altimmune (ALT) in Q3 2024, closing a stake of 10,590 shares — an estimated $70.4K sold.

Principal Financial Group first reported a position in ALT in Q2 2016 and held it in 9 quarters. The position peaked at $2.47M in Q1 2021. 169 funds tracked by Wall St. Rank hold ALT as of Q3 2024.

  • Principal Financial Group reported no remaining Altimmune position as of Q3 2024 after selling out during the quarter.
  • Principal Financial Group sold 10,590 Altimmune shares in Q3 2024, an estimated $70.4K.
  • Principal Financial Group first reported a position in Altimmune in Q2 2016 and held it in 9 quarters.
  • Principal Financial Group's Altimmune position peaked at $2.47M in Q1 2021.
  • 169 funds tracked by Wall St. Rank held Altimmune as of Q3 2024.

Based on Principal Financial Group's 13F filing for Q3 2024, filed 31 Oct 2024.